Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Bristol Myers Squibb - 51 Year Stock Price History | BMY

Historical daily share price chart and data for Bristol Myers Squibb since 1972 adjusted for splits and dividends. The latest closing stock price for Bristol Myers Squibb as of December 01, 2023 is 50.10.
  • The all-time high Bristol Myers Squibb stock closing price was 77.65 on December 02, 2022.
  • The Bristol Myers Squibb 52-week high stock price is 81.42, which is 62.5% above the current share price.
  • The Bristol Myers Squibb 52-week low stock price is 48.25, which is 3.7% below the current share price.
  • The average Bristol Myers Squibb stock price for the last 52 weeks is 64.65.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Bristol Myers Squibb Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2023 62.3999 69.1646 71.9027 48.4800 50.1000 -27.25%
2022 68.9498 57.4351 77.6546 57.4351 68.8679 19.00%
2021 57.7810 55.6582 63.8031 49.7777 57.8714 2.89%
2020 53.9543 55.6789 59.2742 40.7878 56.2476 0.39%
2019 43.2669 44.1982 56.0281 37.0253 56.0281 27.86%
2018 48.2041 50.3387 57.0031 41.1044 43.8188 -12.91%
2017 46.8104 47.5167 53.6558 37.6687 50.3141 7.72%
2016 50.0291 52.6155 60.9375 39.3482 46.7095 -13.50%
2015 49.9437 45.6533 55.2024 44.4555 53.9970 19.24%
2014 39.3924 39.0030 46.7354 35.0072 45.2851 14.18%
2013 32.1569 23.6723 39.9042 23.6723 39.6596 69.95%
2012 23.4845 24.0949 25.6252 22.0612 23.3357 -3.78%
2011 19.6085 17.4604 24.2876 16.6105 24.2532 39.43%
2010 16.5547 16.2368 18.1352 14.3859 17.3948 8.74%
2009 13.3206 14.3143 16.2429 10.4960 15.9961 14.78%
2008 12.5189 14.7890 15.3267 10.2077 13.9367 -6.05%
2007 15.8945 14.3443 17.8096 14.1920 14.8337 4.75%
2006 12.7614 11.9421 14.1613 10.7676 14.1613 19.92%
2005 12.2322 12.4900 13.2968 10.8065 11.8085 -6.16%
2004 12.1393 13.9262 14.5383 10.9228 12.5833 -7.27%
2003 11.6784 10.9175 13.5703 9.5999 13.5703 29.02%
2002 13.6218 22.1332 22.3291 9.1145 10.5177 -52.36%
2001 24.6331 30.3715 30.3715 21.2112 22.0769 -29.71%
2000 24.5610 26.9247 31.4079 18.2510 31.4079 17.10%
1999 28.3325 26.8928 32.5654 23.8486 26.8203 -2.80%
1998 22.2909 19.3061 27.5940 18.3228 27.5940 42.93%
1997 15.3917 10.7132 19.8735 10.7132 19.3061 77.07%
1996 9.0374 8.2264 11.4982 7.7963 10.9032 32.15%
1995 6.5239 5.4873 8.2745 5.4064 8.2504 53.26%
1994 5.0365 5.0722 5.5677 4.5290 5.3832 6.10%
1993 4.9987 5.5720 5.5720 4.3984 5.0739 -9.48%
1992 5.8714 7.1097 7.1500 5.1105 5.6052 -21.16%
1991 6.2734 5.2052 7.1097 4.7950 7.1097 35.83%
1990 4.5165 4.2773 5.2455 3.8438 5.2341 24.56%
1989 3.6373 3.1981 4.2468 3.1707 4.2022 28.87%
1988 3.0368 3.0826 3.2786 2.7441 3.2608 9.89%
1987 3.3994 3.0067 3.9201 2.6015 2.9672 0.77%
1986 2.6973 2.3432 3.1314 2.1518 2.9444 24.71%
1985 2.0886 1.8264 2.4098 1.7730 2.3610 26.48%
1984 1.6532 1.5370 1.8710 1.4879 1.8667 23.98%
1983 1.3837 1.1938 1.6974 1.1226 1.5057 25.65%
1982 1.0591 0.9399 1.3052 0.9111 1.1983 26.58%
1981 0.9327 0.9088 1.0424 0.8220 0.9467 5.46%
1980 0.7255 0.6482 0.9155 0.5479 0.8977 36.16%
1979 0.6157 0.6347 0.6816 0.5568 0.6593 3.50%
1978 0.6001 0.5948 0.7083 0.5034 0.6370 6.31%
1977 0.5804 0.6058 0.6347 0.5145 0.5992 -2.00%
1976 0.6514 0.6170 0.7372 0.5512 0.6114 -0.36%
1975 0.5532 0.4554 0.6559 0.4198 0.6136 37.39%
1974 0.4139 0.4165 0.5001 0.2817 0.4466 8.11%
1973 0.5448 0.6103 0.6359 0.3920 0.4131 -32.80%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $101.941B $46.159B
Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers has a strong oncology portfolio, comprising other drugs like Revlimid, Pomalyst, Sprycel, Yervoy and Empliciti. It also has important immunology and cardiovascular drugs like Orencia and Eliquis. It's experiencing growth in both the Eliquis brand and the market, while also advancing its Factor XIa inhibitor program. After the sale of the global Diabetes business to AstraZeneca and the discontinuation of discovery research efforts in virology, it's focusing solely on research in core therapeutic areas like oncology, immuno-oncology, immunoscience, cardiovascular, fibrosis and genetically defined diseases. It acquried Celgene Corporation and MyoKardia. It received regulatory approvals for Reblozyl and Inrebic.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $145.809B 15.11
Gilead Sciences (GILD) United States $96.755B 11.64
Vertex Pharmaceuticals (VRTX) United States $90.488B 26.60
Regeneron Pharmaceuticals (REGN) United States $88.777B 21.24
CSL (CSLLY) Australia $85.271B 0.00
GSK (GSK) United Kingdom $74.878B 9.70
Seagen (SGEN) United States $39.927B 0.00
Biogen (BIIB) United States $33.999B 14.82
Moderna (MRNA) United States $30.438B 0.00
Argenex SE (ARGX) Netherlands $26.815B 0.00
BioNTech SE (BNTX) Germany $23.629B 8.62
Alnylam Pharmaceuticals (ALNY) United States $21.511B 0.00
Genmab (GMAB) Denmark $21.122B 34.01
BeiGene (BGNE) Cayman Islands $17.858B 0.00
Illumina (ILMN) United States $17.435B 126.20
BioMarin Pharmaceutical (BMRN) United States $17.409B 84.02
Exact Sciences (EXAS) United States $12.122B 0.00
Incyte (INCY) United States $12.105B 23.49
Legend Biotech (LEGN) United States $10.906B 0.00
Bio-Techne Corp (TECH) United States $10.212B 36.69
QIAGEN (QGEN) Netherlands $9.451B 20.22
Sino Biopharmaceutical (SBMFF) Hong Kong, SAR China $9.307B 0.00
Repligen (RGEN) United States $9.209B 79.30
Bio-Rad Laboratories (BIO.B) United States $8.944B 25.62
Verona Pharma American Depositary Share (VRNA) United Kingdom $8.594B 0.00
Roivant Sciences (ROIV) United Kingdom $7.919B 0.00
Sarepta Therapeutics (SRPT) United States $7.899B 0.00
Karuna Therapeutics (KRTX) United States $7.414B 0.00
Apellis Pharmaceuticals (APLS) United States $7.297B 0.00
Exelixis (EXEL) United States $6.823B 78.36
Swedish Orphan Biovitrum (BIOVF) Sweden $6.213B 21.93
Intra-Cellular Therapies (ITCI) United States $6.048B 0.00
Ascendis Pharma (ASND) Denmark $6.000B 0.00
Immunovant (IMVT) United States $5.866B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.453B 0.00
Halozyme Therapeutics (HALO) United States $5.243B 17.72
Vaxcyte (PCVX) United States $5.120B 0.00
Blueprint Medicines (BPMC) United States $4.380B 0.00
Nuvalent (NUVL) United States $4.146B 0.00
Alkermes (ALKS) Ireland $4.054B 31.96
Mirati Therapeutics (MRTX) United States $4.004B 0.00
Insmed (INSM) United States $3.794B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.710B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.298B 0.00
Cytokinetics (CYTK) United States $3.292B 0.00
Amicus Therapeutics (FOLD) United States $3.290B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.233B 0.00
Axsome Therapeutics (AXSM) United States $3.218B 0.00
Guardant Health (GH) United States $3.107B 0.00
Ginkgo Bioworks Holdings (DNA) United States $3.029B 0.00
Krystal Biotech (KRYS) United States $2.997B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.879B 0.00
Fortrea Holdings (FTRE) United States $2.764B 0.00
Structure Therapeutics (GPCR) United States $2.763B 0.00
Intellia Therapeutics (NTLA) United States $2.762B 0.00
Zai Lab (ZLAB) China $2.718B 0.00
Biohaven (BHVN) United States $2.701B 0.00
Arcellx (ACLX) United States $2.677B 0.00
Denali Therapeutics (DNLI) United States $2.622B 0.00
Immunocore Holdings (IMCR) United Kingdom $2.576B 0.00
ImmunityBio (IBRX) United States $2.524B 0.00
Galapagos (GLPG) Belgium $2.492B 0.00
Zealand Pharma (ZLDPF) Denmark $2.469B 0.00
NeoGenomics (NEO) United States $2.422B 0.00
Beam Therapeutics (BEAM) United States $2.410B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.408B 0.00
Certara (CERT) United States $2.340B 39.57
Rocket Pharmaceuticals (RCKT) United States $2.112B 0.00
IDEAYA Biosciences (IDYA) United States $2.039B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.997B 0.00
SpringWorks Therapeutics (SWTX) United States $1.996B 0.00
Bavarian Nordic (BVNRY) Denmark $1.887B 11.37
Neumora Therapeutics (NMRA) United States $1.883B 0.00
Prothena (PRTA) Ireland $1.872B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.785B 11.37
Dynavax Technologies (DVAX) United States $1.783B 35.36
Vericel (VCEL) United States $1.700B 0.00
Iovance Biotherapeutics (IOVA) United States $1.602B 0.00
Myriad Genetics (MYGN) United States $1.581B 0.00
Celldex Therapeutics (CLDX) United States $1.513B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.492B 0.00
POINT Biopharma Global (PNT) United States $1.471B 15.33
Merus (MRUS) Netherlands $1.451B 0.00
RayzeBio (RYZB) United States $1.431B 0.00
Twist Bioscience (TWST) United States $1.429B 0.00
AbCellera Biologics (ABCL) Canada $1.402B 0.00
Disc Medicine (IRON) United States $1.346B 0.00
Vir Biotechnology (VIR) United States $1.304B 0.00
Viking Therapeutics (VKTX) United States $1.301B 0.00
Arvinas (ARVN) United States $1.299B 0.00
CureVac (CVAC) Germany $1.231B 0.00
Morphic Holding (MORF) United States $1.214B 0.00
Arcus Biosciences (RCUS) United States $1.203B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.182B 0.00
Belite Bio (BLTE) United States $1.162B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.154B 0.00
Kymera Therapeutics (KYMR) United States $1.152B 0.00
Geron (GERN) United States $1.081B 0.00
Protagonist Therapeutics (PTGX) United States $1.071B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.067B 0.00
Inhibrx (INBX) United States $1.059B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.037B 0.00
ANI Pharmaceuticals (ANIP) United States $1.034B 13.78
Ligand Pharmaceuticals (LGND) United States $1.020B 16.74
MannKind (MNKD) United States $1.016B 0.00
Apogee Therapeutics (APGE) United States $1.007B 0.00
Northwest Biotherapeutics (NWBO) United States $0.991B 0.00
Akero Therapeutics (AKRO) United States $0.984B 0.00
Cytek Biosciences (CTKB) United States $0.972B 0.00
Scholar Rock Holding (SRRK) United States $0.970B 0.00
MiMedx (MDXG) United States $0.930B 0.00
Keros Therapeutics (KROS) United States $0.918B 0.00
Viridian Therapeutics (VRDN) United States $0.906B 0.00
Editas Medicine (EDIT) United States $0.880B 0.00
REGENXBIO (RGNX) United States $0.865B 0.00
ADMA Biologics Inc (ADMA) United States $0.861B 0.00
Pliant Therapeutics (PLRX) United States $0.848B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.802B 0.00
Olema Pharmaceuticals (OLMA) United States $0.799B 0.00
Sana Biotechnology (SANA) United States $0.796B 0.00
Tango Therapeutics (TNGX) United States $0.791B 0.00
Prime Medicine (PRME) United States $0.784B 0.00
Ambrx Biopharma (AMAM) United States $0.782B 0.00
Pharming Group (PHAR) Netherlands $0.773B 0.00
Pharming Group (PHGUF) Netherlands $0.744B 0.00
Kura Oncology (KURA) United States $0.740B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.729B 0.00
HilleVax (HLVX) United States $0.698B 0.00
Replimune (REPL) United States $0.692B 0.00
Immatics (IMTX) Germany $0.691B 0.00
Cabaletta Bio (CABA) United States $0.686B 0.00
Cogent Biosciences (COGT) United States $0.686B 0.00
Adaptive Biotechnologies (ADPT) United States $0.680B 0.00
ACELYRIN, INC (SLRN) United States $0.670B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.665B 9.49
Novavax (NVAX) United States $0.662B 0.00
Pharma Mar (PHMMF) Spain $0.645B 0.00
Sinovac Biotech (SVA) China $0.644B 0.00
Zymeworks (ZYME) United States $0.641B 2.94
Revance Therapeutics (RVNC) United States $0.636B 0.00
89BIO (ETNB) United States $0.635B 0.00
CARGO Therapeutics (CRGX) $0.630B 0.00
Anavex Life Sciences (AVXL) United States $0.621B 0.00
Vera Therapeutics (VERA) United States $0.615B 0.00
Avidity Biosciences (RNA) United States $0.600B 0.00
Biomea Fusion (BMEA) United States $0.596B 0.00
Rapt Therapeutics (RAPT) United States $0.556B 0.00
WAVE Life Sciences (WVE) Singapore $0.546B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.539B 0.00
Castle Biosciences (CSTL) United States $0.537B 0.00
PureTech Health (PRTC) United States $0.533B 0.00
Icosavax (ICVX) United States $0.526B 0.00
Tarsus Pharmaceuticals (TARS) United States $0.525B 0.00
MaxCyte (MXCT) United States $0.516B 0.00
Caribou Biosciences (CRBU) United States $0.503B 0.00
Tyra Biosciences (TYRA) United States $0.500B 0.00
AN2 Therapeutics (ANTX) United States $0.499B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.486B 0.00
Travere Therapeutics (TVTX) United States $0.482B 0.00
Liquidia Technologies (LQDA) United States $0.472B 0.00
Alector (ALEC) United States $0.468B 0.00
Bluebird Bio (BLUE) United States $0.466B 0.00
Oric Pharmaceuticals (ORIC) United States $0.451B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.450B 0.00
LianBio (LIAN) United States $0.449B 0.00
Aerovate Therapeutics (AVTE) United States $0.447B 0.00
Entrada Therapeutics (TRDA) United States $0.447B 0.00
23andMe Holding (ME) United States $0.428B 0.00
Allogene Therapeutics (ALLO) United States $0.424B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.418B 0.00
Janux Therapeutics (JANX) United States $0.417B 0.00
ALX Oncology Holdings (ALXO) United States $0.399B 0.00
AnaptysBio (ANAB) United States $0.399B 0.00
Edgewise Therapeutics (EWTX) United States $0.393B 0.00
Adlai Nortye (ANL) Cayman Islands $0.391B 0.00
Gracell Biotechnologies (GRCL) China $0.384B 0.00
Third Harmonic Bio (THRD) United States $0.373B 0.00
Cullinan Oncology (CGEM) United States $0.370B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.369B 0.00
Nautilus Biotechnology (NAUT) United States $0.366B 0.00
Oculis Holding AG (OCS) Switzerland $0.364B 0.00
IGM Biosciences (IGMS) United States $0.363B 0.00
Celcuity (CELC) United States $0.360B 0.00
Genelux (GNLX) United States $0.356B 0.00
ITeos Therapeutics (ITOS) United States $0.354B 0.00
MeiraGTx Holdings (MGTX) United States $0.342B 0.00
UniQure (QURE) Netherlands $0.341B 0.00
Arbutus Biopharma (ABUS) United States $0.340B 0.00
Nurix Therapeutics (NRIX) United States $0.335B 0.00
Voyager Therapeutics (VYGR) United States $0.335B 6.19
Immunome (IMNM) United States $0.333B 0.00
Anika Therapeutics (ANIK) United States $0.332B 0.00
Terns Pharmaceuticals (TERN) United States $0.323B 0.00
Avid Bioservices (CDMO) United States $0.315B 0.00
Aura Biosciences (AURA) United States $0.313B 0.00
TScan Therapeutics (TCRX) United States $0.310B 0.00
Fulcrum Therapeutics (FULC) United States $0.309B 0.00
Urogen Pharma (URGN) United States $0.306B 0.00
Amarin (AMRN) Ireland $0.303B 0.00
Agenus (AGEN) United States $0.299B 0.00
Precigen (PGEN) United States $0.296B 0.00
Mineralys Therapeutics (MLYS) United States $0.296B 0.00
Nuvation Bio (NUVB) United States $0.291B 0.00
AC Immune (ACIU) Switzerland $0.284B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.282B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.277B 0.00
Humacyte (HUMA) United States $0.276B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.269B 0.00
Fate Therapeutics (FATE) United States $0.261B 0.00
Atea Pharmaceuticals (AVIR) United States $0.260B 0.00
Coherus BioSciences (CHRS) United States $0.256B 0.00
Poseida Therapeutics (PSTX) United States $0.252B 0.00
Erasca (ERAS) United States $0.252B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.243B 0.00
Immuneering (IMRX) United States $0.242B 0.00
Inozyme Pharma (INZY) United States $0.238B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.233B 0.00
Akoya Biosciences (AKYA) United States $0.232B 0.00
Mersana Therapeutics (MRSN) United States $0.229B 0.00
Ovid Therapeutics (OVID) United States $0.226B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.224B 18.57
Repare Therapeutics (RPTX) Canada $0.224B 0.00
Inventiva S.A (IVA) France $0.224B 0.00
Lifecore Biomedical (LFCR) United States $0.223B 0.00
Mesoblast (MESO) Australia $0.221B 0.00
Renovaro Biosciences (RENB) United States $0.221B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.216B 0.00
Compass Therapeutics (CMPX) United States $0.215B 0.00
Scilex Holding (SCLX) United States $0.211B 0.00
Kamada (KMDA) Israel $0.208B 18.60
Zura Bio (ZURA) United States $0.206B 0.00
Allakos (ALLK) United States $0.199B 0.00
ScPharmaceuticals (SCPH) United States $0.197B 0.00
Innate Pharma S.A (IPHA) France $0.197B 0.00
Gossamer Bio (GOSS) United States $0.191B 0.00
Arcutis Biotherapeutics (ARQT) United States $0.188B 0.00
Applied Therapeutics (APLT) United States $0.187B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.185B 0.00
CorMedix Inc (CRMD) United States $0.184B 0.00
Puma Biotechnology (PBYI) United States $0.178B 46.88
Verastem (VSTM) United States $0.177B 0.00
XOMA (XOMA) United States $0.177B 0.00
Stoke Therapeutics (STOK) United States $0.176B 0.00
Alimera Sciences (ALIM) United States $0.176B 0.00
Prima BioMed (IMMP) Australia $0.175B 0.00
INmune Bio (INMB) United States $0.173B 0.00
Astria Therapeutics (ATXS) United States $0.172B 0.00
Codexis (CDXS) United States $0.172B 0.00
Theseus Pharmaceuticals (THRX) United States $0.171B 0.00
Invivyd (IVVD) United States $0.170B 0.00
Cellectis S.A (CLLS) France $0.169B 0.00
Sutro Biopharma (STRO) United States $0.168B 0.00
Dianthus Therapeutics (DNTH) United States $0.167B 0.00
Adocia (ADOCY) France $0.166B 0.00
PDS Biotechnology (PDSB) United States $0.163B 0.00
GENFIT S.A (GNFT) France $0.163B 0.00
Absci (ABSI) United States $0.162B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.156B 0.00
Molecular Partners AG (MOLN) Switzerland $0.154B 0.00
Cartesian Therapeutics (RNAC) United States $0.154B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.153B 0.00
Praxis Precision Medicines (PRAX) United States $0.151B 0.00
Greenwich LifeSciences (GLSI) United States $0.150B 0.00
Gritstone Bio (GRTS) United States $0.146B 0.00
Nuvectis Pharma (NVCT) United States $0.146B 0.00
DBV Technologies S.A (DBVT) France $0.143B 0.00
Opthea (OPT) Australia $0.142B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.141B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.141B 0.00
Design Therapeutics (DSGN) United States $0.141B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.140B 0.00
Seres Therapeutics (MCRB) United States $0.138B 0.00
TELA Bio (TELA) United States $0.138B 0.00
Kodiak Sciences (KOD) United States $0.135B 0.00
I-Mab (IMAB) China $0.135B 0.00
Tenaya Therapeutics (TNYA) United States $0.134B 0.00
Nkarta (NKTX) United States $0.133B 0.00
Graphite Bio (GRPH) United States $0.131B 0.00
Vor Biopharma (VOR) $0.130B 0.00
Ventyx Biosciences (VTYX) United States $0.130B 0.00
PepGen (PEPG) United States $0.128B 0.00
Annexon (ANNX) United States $0.125B 0.00
Emergent Biosolutions (EBS) United States $0.124B 0.00
X4 Pharmaceuticals (XFOR) United States $0.124B 0.00
Omega Therapeutics (OMGA) United States $0.124B 0.00
Oncobiologics (OTLK) United States $0.123B 0.00
Aadi Bioscience (AADI) United States $0.122B 0.00
Rani Therapeutics Holdings (RANI) United States $0.122B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.121B 0.00
XBiotech (XBIT) United States $0.121B 0.00
EnGene Holdings (ENGN) United States $0.119B 0.00
Abeona Therapeutics (ABEO) United States $0.115B 0.00
Vigil Neuroscience (VIGL) United States $0.115B 0.00
Genetron Holdings (GTH) China $0.114B 0.00
BioXcel Therapeutics (BTAI) United States $0.114B 0.00
Vaxxinity (VAXX) United States $0.110B 0.00
Inovio Pharmaceuticals (INO) United States $0.109B 0.00
Cue Biopharma (CUE) United States $0.108B 0.00
Seer (SEER) United States $0.108B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.106B 0.00
Kinnate Biopharma (KNTE) United States $0.106B 0.00
ChromaDex (CDXC) United States $0.106B 0.00
Oncolytics Biotech (ONCY) Canada $0.104B 0.00
G1 Therapeutics (GTHX) United States $0.104B 0.00
Immix Biopharma (IMMX) United States $0.103B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.102B 0.00
Ocugen (OCGN) United States $0.102B 0.00
VistaGen Therapeutics (VTGN) United States $0.099B 0.00
DiaMedica Therapeutics (DMAC) United States $0.098B 0.00
2seventy Bio (TSVT) United States $0.098B 0.00
Genenta Science S.p.A (GNTA) Italy $0.095B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.095B 0.00
Eton Pharmaceuticals (ETON) United States $0.095B 37.00
CytomX Therapeutics (CTMX) United States $0.094B 0.00
Miromatrix Medical (MIRO) United States $0.093B 0.00
Werewolf Therapeutics (HOWL) United States $0.092B 0.00
MediciNova (MNOV) United States $0.087B 0.00
Annovis Bio (ANVS) United States $0.087B 0.00
BRIACELL THERAP (BCTX) Canada $0.086B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.085B 0.00
BioAtla (BCAB) United States $0.085B 0.00
Rallybio (RLYB) United States $0.084B 0.00
Adverum Biotechnologies (ADVM) United States $0.084B 0.00
Shattuck Labs (STTK) United States $0.083B 0.00
China Health Industries Holdings (CHHE) China $0.082B 0.00
Apollomics (APLM) Taiwan $0.082B 0.00
Sagimet Biosciences (SGMT) United States $0.081B 0.00
Sangamo Therapeutics (SGMO) United States $0.081B 0.00
IO Biotech (IOBT) Denmark $0.080B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.079B 0.00
C4 Therapeutics (CCCC) United States $0.079B 0.00
ATyr Pharma (LIFE) United States $0.074B 0.00
NKGen Biotech (NKGN) United States $0.074B 0.00
Ikena Oncology (IKNA) United States $0.072B 0.00
Trevi Therapeutics (TRVI) United States $0.071B 0.00
Cidara Therapeutics (CDTX) United States $0.071B 0.00
Kronos Bio (KRON) United States $0.070B 0.00
Curis (CRIS) United States $0.070B 0.00
Jasper Therapeutics (JSPR) United States $0.070B 0.00
Coya Therapeutics (COYA) United States $0.069B 0.00
Ocuphire Pharma (OCUP) United States $0.068B 2.28
Alpha Teknova (TKNO) United States $0.068B 0.00
Affimed (AFMD) Germany $0.067B 0.00
Adagene (ADAG) China $0.067B 0.00
Atara Biotherapeutics (ATRA) United States $0.066B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.065B 0.00
Bionano Genomics (BNGO) United States $0.064B 0.00
Checkpoint Therapeutics (CKPT) United States $0.064B 0.00
Clearside Biomedical (CLSD) United States $0.064B 0.00
Enzo Biochem (ENZ) United States $0.064B 0.00
NGM Biopharmaceuticals (NGM) United States $0.064B 0.00
Eyenovia (EYEN) United States $0.063B 0.00
Spero Therapeutics (SPRO) United States $0.062B 13.00
Kezar Life Sciences (KZR) United States $0.061B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.061B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.061B 0.00
Solid Biosciences (SLDB) United States $0.061B 0.00
Compugen (CGEN) Israel $0.061B 0.00
Spruce Biosciences (SPRB) United States $0.061B 0.00
InflaRx (IFRX) Germany $0.060B 0.00
Leap Therapeutics (LPTX) United States $0.060B 0.00
Gyre Therapeutics (GYRE) United States $0.059B 0.00
Connect Biopharma Holdings (CNTB) United States $0.058B 0.00
Cara Therapeutics (CARA) United States $0.058B 0.00
AVROBIO (AVRO) United States $0.058B 0.00
Athira Pharma (ATHA) United States $0.057B 0.00
CervoMed (CRVO) United States $0.057B 0.00
Cardiff Oncology (CRDF) United States $0.056B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.056B 0.00
Syros Pharmaceuticals (SYRS) United States $0.056B 0.00
Clene (CLNN) United States $0.056B 0.00
Immunic (IMUX) United States $0.054B 0.00
Adicet Bio (ACET) United States $0.053B 0.00
Beyond Air (XAIR) United States $0.053B 0.00
Aligos Therapeutics (ALGS) United States $0.053B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.052B 0.00
Estrella Immunopharma (ESLA) United States $0.051B 0.00
Dyadic (DYAI) United States $0.051B 0.00
Elicio Therapeutics (ELTX) United States $0.050B 0.00
YS Biopharma (YS) China $0.049B 0.66
SAB Biotherapeutics (SABS) United States $0.049B 0.00
Turnstone Biologics (TSBX) United States $0.049B 0.00
HOOKIPA Pharma (HOOK) United States $0.048B 0.00
OKYO Pharma (OKYO) $0.048B 0.00
Elutia (ELUT) United States $0.048B 0.00
Longeveron (LGVN) United States $0.047B 0.00
Instil Bio (TIL) United States $0.045B 0.00
Celularity (CELU) United States $0.044B 0.00
Precision BioSciences (DTIL) United States $0.043B 0.00
Intensity Therapeutics (INTS) United States $0.043B 0.00
Kineta (KA) United States $0.043B 0.00
Quince Therapeutics (QNCX) United States $0.041B 0.00
HCW Biologics (HCWB) United States $0.041B 0.00
Lantern Pharma (LTRN) United States $0.041B 0.00
Rain Oncology (RAIN) United States $0.040B 0.00
Prenetics Global (PRE) Cayman Islands $0.040B 48.37
Theratechnologies (THTX) Canada $0.039B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.039B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.039B 0.00
Passage Bio (PASG) United States $0.037B 0.00
Cognition Therapeutics (CGTX) United States $0.037B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.036B 0.00
MiNK Therapeutics (INKT) United States $0.036B 0.00
Dare Bioscience (DARE) United States $0.035B 0.00
Gamida Cell (GMDA) United States $0.035B 0.00
Galena Biopharma (SLS) United States $0.035B 0.00
BeyondSpring (BYSI) United States $0.034B 0.00
Bolt Biotherapeutics (BOLT) United States $0.034B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.033B 0.00
NextCure (NXTC) United States $0.033B 0.00
Cyclo Therapeutics (CYTH) United States $0.033B 0.00
Neoleukin Therapeutics (NLTX) United States $0.033B 0.00
Biora Therapeutics (BIOR) United States $0.032B 0.00
Rezolute (RZLT) United States $0.032B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.032B 0.00
VTv Therapeutics (VTVT) United States $0.032B 0.00
Science 37 Holdings (SNCE) United States $0.030B 0.00
Xilio Therapeutics (XLO) United States $0.029B 0.00
Evogene (EVGN) Israel $0.028B 0.00
Ocean Biomedical (OCEA) United States $0.028B 0.00
UNITY Biotechnology (UBX) United States $0.028B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.028B 0.00
IN8bio (INAB) United States $0.027B 0.00
Freeline Therapeutics Holdings (FRLN) United Kingdom $0.027B 0.00
Candel Therapeutics (CADL) United States $0.026B 0.00
Pluri (PLUR) Israel $0.024B 0.00
Lumos Pharma (LUMO) United States $0.024B 0.00
Portage Biotech (PRTG) $0.024B 0.00
Synlogic (SYBX) United States $0.024B 0.00
Purple Biotech (PPBT) Israel $0.023B 0.00
Evaxion Biotech (EVAX) Denmark $0.023B 0.00
Promis Neurosciences (PMN) Canada $0.022B 0.00
CalciMedica (CALC) United States $0.022B 0.00
NuCana (NCNA) United Kingdom $0.022B 0.00
Elevation Oncology (ELEV) United States $0.022B 0.00
Aptose Biosciences (APTO) Canada $0.021B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.021B 0.00
TFF Pharmaceuticals (TFFP) United States $0.020B 0.00
Femasys (FEMY) United States $0.020B 0.00
Senti Biosciences (SNTI) United States $0.020B 0.00
Fortress Biotech (FBIO) United States $0.019B 0.00
Cocrystal Pharma (COCP) United States $0.019B 0.00
Entera Bio (ENTX) Israel $0.019B 0.00
Equillium (EQ) United States $0.019B 0.00
Lisata Therapeutics (LSTA) United States $0.018B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.018B 0.00
Moleculin Biotech (MBRX) United States $0.018B 0.00
Forte Biosciences (FBRX) United States $0.018B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.017B 0.00
Sensei Biotherapeutics (SNSE) United States $0.017B 0.00
KALA BIO (KALA) United States $0.016B 0.00
Galecto (GLTO) Denmark $0.016B 0.00
Lexaria Bioscience (LEXX) Canada $0.016B 0.00
BioAffinity Technologies (BIAF) United States $0.016B 0.00
Mainz Biomed (MYNZ) Germany $0.016B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.015B 0.00
Vincerx Pharma (VINC) United States $0.015B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.015B 0.00
PHAXIAM Therapeutics S.A (PHXM) France $0.015B 0.00
VBI Vaccines (VBIV) United States $0.015B 0.00
BioCardia (BCDA) United States $0.015B 0.00
Orgenesis (ORGS) United States $0.014B 0.00
Talis Biomedical (TLIS) United States $0.014B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.014B 0.00
GENPREX (GNPX) United States $0.014B 0.00
Aprea Therapeutics (APRE) United States $0.014B 0.00
Mustang Bio (MBIO) United States $0.013B 0.00
Genetic Technologies (GENE) Australia $0.013B 0.00
Telesis Bio (TBIO) United States $0.013B 0.00
Aytu BioPharma (AYTU) United States $0.013B 0.00
Landos Biopharma (LABP) United States $0.013B 0.00
Acorda Therapeutics (ACOR) United States $0.013B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.013B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
CNS Pharmaceuticals (CNSP) United States $0.011B 0.00
Bionomics (BNOX) Australia $0.011B 0.00
Aileron Therapeutics (ALRN) United States $0.011B 0.00
GeoVax Labs (GOVX) United States $0.011B 0.00
Virios Therapeutics (VIRI) United States $0.011B 0.00
Organovo Holdings (ONVO) United States $0.011B 0.00
Edesa Biotech (EDSA) Canada $0.010B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.010B 0.00
AEterna Zentaris (AEZS) Canada $0.010B 0.00
ARAVIVE, INC (ARAV) United States $0.010B 0.00
ABVC BioPharma (ABVC) United States $0.010B 0.00
GT Biopharma (GTBP) United States $0.009B 0.00
Tenax Therapeutics (TENX) United States $0.009B 0.00
Imunon (IMNN) United States $0.009B 0.00
Trevena (TRVN) United States $0.009B 0.00
Biorestorative Therapies (BRTX) United States $0.009B 0.00
Atreca (BCEL) United States $0.009B 0.00
Applied Molecular Transport (AMTI) United States $0.009B 0.00
Notable Labs (NTBL) United States $0.008B 0.00
Benitec Biopharma (BNTC) United States $0.008B 0.00
Vaccinex (VCNX) United States $0.008B 0.00
Galera Therapeutics (GRTX) United States $0.008B 0.00
Soligenix (SNGX) United States $0.008B 0.00
AquaBounty Technologies (AQB) United States $0.008B 0.00
Evelo Biosciences (EVLO) United States $0.007B 0.00
Sunshine Biopharma (SBFM) Canada $0.007B 0.00
Seelos Therapeutics (SEEL) United States $0.007B 0.00
Pulmatrix (PULM) United States $0.007B 0.00
Novogen (KZIA) Australia $0.007B 0.00
Alzamend Neuro (ALZN) United States $0.007B 0.00
RenovoRx (RNXT) United States $0.007B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.007B 0.00
Prana Biotechnology (ATHE) Australia $0.007B 0.00
Pasithea Therapeutics (KTTA) United States $0.007B 0.00
Eterna Therapeutics (ERNA) United States $0.007B 0.00
Cadrenal Therapeutics (CVKD) United States $0.007B 0.00
NexImmune (NEXI) United States $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
TRACON Pharmaceuticals (TCON) United States $0.006B 0.00
Cyclerion Therapeutics (CYCN) United States $0.006B 0.00
Chemomab Therapeutics (CMMB) Israel $0.006B 0.00
Cingulate (CING) United States $0.006B 0.00
Biofrontera (BFRI) United States $0.006B 0.00
Palisade Bio (PALI) United States $0.006B 0.04
Avalon GloboCare (ALBT) United States $0.006B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.005B 0.00
Windtree Therapeutics (WINT) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
Titan Pharmaceuticals (TTNP) United States $0.005B 0.00
Biophytis SA (BPTS) France $0.005B 0.00
Hoth Therapeutics (HOTH) United States $0.005B 0.00
Monopar Therapeutics (MNPR) United States $0.005B 0.00
Blue Water Biotech (BWV) United States $0.005B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.005B 0.00
Revelation Biosciences (REVB) United States $0.005B 0.00
Invo BioScience (INVO) United States $0.005B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.005B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Exicure (XCUR) United States $0.004B 0.28
Enveric Biosciences (ENVB) United States $0.004B 0.00
First Wave BioPharma (FWBI) United States $0.004B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.003B 0.00
NeuBase Therapeutics (NBSE) United States $0.003B 0.00
Atrinsic (PTIX) United States $0.003B 0.00
Aptevo Therapeutics (APVO) United States $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
Aceragen (ACGN) United States $0.003B 0.00
Panbela Therapeutics (PBLA) United States $0.003B 0.00
Ensysce Biosciences (ENSC) United States $0.003B 0.00
ThermoGenesis Holdings (THMO) United States $0.003B 0.00
Allarity Therapeutics (ALLR) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.003B 0.00
GRI Bio (GRI) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Adial Pharmaceuticals (ADIL) United States $0.002B 0.00
Clovis Oncology (CLVSQ) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.12
PaxMedica (PXMD) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.001B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.001B 0.00
Kintara Therapeutics (KTRA) United States $0.001B 0.00
Tharimmune (THAR) United States $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.000B 0.00
MorphoSys AG (MOR) Germany $0.000B 17.97
ARCA Biopharma (ABIO) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
GH Research (GHRS) Ireland $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00